Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01670695

A Prospective Cohort Study of IgG4RD in China

This is an cohort study to investigate the disease course and treatment response of patients with IgG4-related disease.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Immunoglobulin G4-related disease (IgG4-RD) is a recently defined emerging clinical entity characterized by tissue infiltration by IgG4-positive plasma cells, tissue fibrosclerosis and elevated serum IgG4 concentration.

In this study, patients with IgG4-RD will be investigated, including clinical presentation, laboratory findings and imaging study. All patients will be treated by standard care and follow-uped for at least 6 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males and females
  • Age 18-75 years old with informed consent
  • Patients with IgG4-RD:
  • swelling, sclerosing and inflammatory involvement of one or more organ, including sclerosing pancreatitis, sclerosing cholangitis, inflammatory pseudotumors, retroperitoneal or mediastinal fibrosis, interstitial nephritis, hypophysitis, sclerosing dacryoadenitis, sialadenitis, inflammatory aortic aneurysm, lymphadenopathy, or other inflammatory conditions;
  • elevated serum IgG4 (>1.35 g/L)
  • histopathologic features of fibrosis and/or lymphocytic and polyclonal plasma cell infiltration (and IgG4+ plasma cells on immunohistology when performed);
  • exclusion of other diseases.

Exclusion criteria

  • Females planning to bear a child recently or with childbearing potential
  • Concurrent severe and/or uncontrolled and/or unstable diseases
  • Patient with malignancy

Treatment and study plan

Primary outcomes

  1. Clinical Response

    Time frame: 6 months

    Clinical Response is measured by IgG4-RD Responder Index, including organ/site score and serum IgG4 level.

Study contacts

Contact information is provided by the study sponsor or research team.

Hua Chen, MD

CONTACT

[email protected]

86-10-69158797

Sponsors and collaborators

Lead sponsor

Peking Union Medical College Hospital

Other

Registry information

Official study title

Cohort Study of Patients With IgG4-Related Disease

Important dates

Study start
2012
Primary completion
2032
Study completion
2032
First posted
Aug 22, 2012
Registry last updated
Apr 11, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.